Nationwide Fund Advisors - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 112 filers reported holding THERAVANCE INC in Q1 2015. The put-call ratio across all filers is 57.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$588,000
+48.5%
55,747
+1.2%
0.00%
+50.0%
Q3 2015$396,000
-60.2%
55,0960.0%0.00%
-50.0%
Q2 2015$996,000
+5.1%
55,096
-8.7%
0.00%0.0%
Q1 2015$948,000
+7.1%
60,316
-3.6%
0.00%0.0%
Q4 2014$885,000
-18.4%
62,575
-1.4%
0.00%
-20.0%
Q3 2014$1,084,000
-42.6%
63,437
+0.0%
0.01%
-37.5%
Q2 2014$1,888,000
-45.7%
63,412
-25.4%
0.01%
-50.0%
Q3 2013$3,476,000
+15.5%
85,000
+8.9%
0.02%0.0%
Q2 2013$3,009,00078,0840.02%
Other shareholders
THERAVANCE INC shareholders Q1 2015
NameSharesValueWeighting ↓
Baupost Group 19,815,983$338,655,0005.90%
Litespeed Management, L.L.C. 2,670,695$45,642,0001.76%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,790,913$47,697,0001.76%
Proxima Capital Management, LLC 915,000$15,637,0001.69%
IRIDIAN ASSET MANAGEMENT LLC/CT 8,196,372$140,076,0001.44%
PERRY CAPITAL 1,831,099$31,293,0001.14%
Roundview Capital LLC 140,145$2,395,0001.08%
SECTORAL ASSET MANAGEMENT INC 971,438$16,602,0000.70%
Realm Partners LLC 139,982$2,392,0000.68%
BB BIOTECH AG 743,244$12,702,0000.52%
View complete list of THERAVANCE INC shareholders